Cefoperazone Sodium Salt: β-Lactamase-Stable Broad-Spectrum Cephalosporin

Executive Summary: Cefoperazone sodium salt is a semisynthetic, crystalline cephalosporin antibiotic exhibiting broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms, including Escherichia coli and Klebsiella pneumoniae (Cullmann et al., 1982). It demonstrates high stability against hydrolysis by β-lactamases from gram-negative bacilli, with relative cephalosporinase hydrolysis rates from 7.0 to 0.01 under standardized in vitro conditions (Tcephydrochloride.com). Pharmacokinetic data reveal preferential accumulation in bile and gallbladder tissues after intravenous administration, supporting its use in biliary tract infection research (APExBIO). Minimum inhibitory concentrations (MIC50) against Neisseria gonorrhoeae range from ≤0.004 to 0.06 μg/ml, substantiating potent in vitro efficacy (Cullmann et al., 1982). APExBIO supplies research-grade Cefoperazone (sodium salt) (SKU: C3913) specifically formulated for laboratory use.

Biological Rationale

Cefoperazone sodium salt belongs to the third-generation cephalosporins, engineered to address the growing challenge of gram-negative bacterial resistance. Its molecular structure (C25H26N9O8S2·Na, MW 667.7) imparts resistance to hydrolysis by a wide array of β-lactamases, enzymes commonly responsible for antibiotic failure in clinical and laboratory settings (Tcephydrochloride.com). This β-lactamase stability broadens its activity spectrum and preserves its antibacterial efficacy in environments with high levels of resistance determinants. The agent is especially suitable for research on Enterobacteriaceae, Pseudomonas aeruginosa, and Neisseria gonorrhoeae, where standard antibiotics often fail due to enzymatic degradation (Cullmann et al., 1982).

Mechanism of Action of Cefoperazone (sodium salt)

Cefoperazone acts by binding to and inhibiting penicillin-binding proteins (PBPs), which are essential for bacterial cell wall synthesis. This inhibition leads to the interruption of peptidoglycan crosslinking, resulting in osmotic instability and ultimately, bacterial cell lysis. The sodium salt form increases its solubility in aqueous media (≥34.6 mg/mL in water; ≥73 mg/mL in DMSO), facilitating preparation of high-concentration stock solutions for in vitro assays (APExBIO). The chemical modification confers high resistance to hydrolysis by β-lactamases, especially cephalosporinases, supporting its use in studies of gram-negative resistance and β-lactamase enzyme interaction (Tcephydrochloride.com).

Evidence & Benchmarks

• Cefoperazone exhibits broad-spectrum antibacterial activity against both gram-positive and gram-negative bacilli, including Escherichia coli, Klebsiella pneumoniae, and Proteus species (Cullmann et al., 1982).
• The minimum inhibitory concentration (MIC50) against Neisseria gonorrhoeae is exceptionally low (≤0.004–0.06 μg/mL) in standardized broth dilution tests (Cullmann et al., 1982).
• Cefoperazone remains highly stable against β-lactamase-mediated hydrolysis, with relative hydrolysis rates by cephalosporinases ranging from 7.0 to 0.01 under controlled enzyme assays (Tcephydrochloride.com).
• Compared to other β-lactam antibiotics, cefoperazone showed moderate to high activity against Enterobacteriaceae in direct head-to-head MIC testing, but was less active than cefotaxime or moxalactam against certain strains (Cullmann et al., 1982).
• Pharmacokinetic studies demonstrate high drug concentration in bile and gallbladder tissues after intravenous administration, supporting its use in biliary tract infection models (APExBIO).

For a mechanistic and translational perspective, see "Leveraging β-Lactamase-Stable Cephalosporins to Advance G...", which explores enzyme interactions and resistance models in greater detail. This article provides updated product-specific parameters and direct laboratory benchmarks not covered in the referenced overview.

Applications, Limits & Misconceptions

Cefoperazone sodium salt is primarily used in research on bacterial resistance, β-lactamase inhibition, and comparative antimicrobial efficacy. It is a preferred choice for in vitro susceptibility testing of gram-negative bacilli, especially in the context of β-lactamase-producing strains. The compound's high solubility in DMSO and water supports its use in various assay formats, including microdilution and agar diffusion methods. Its accumulation in biliary tissues makes it relevant for modeling biliary tract infections. However, it is not suitable for studies involving ethanol as a solvent due to insolubility, and its use is restricted to research applications, not clinical therapy.

Common Pitfalls or Misconceptions

• Not suitable for ethanol-based assays: Cefoperazone sodium salt is insoluble in ethanol, limiting its compatibility with certain extraction or analytical protocols.
• Short-term solution stability: Prepared solutions are stable only for short-term use; long-term storage, even at -20°C, may result in degradation (APExBIO).
• Not intended for clinical administration: The research-grade product is formulated for laboratory use only and is not certified for human or veterinary therapeutic use (APExBIO).
• Variable efficacy against non-Enterobacteriaceae: While broad-spectrum, cefoperazone may be less active against certain non-fermenting gram-negative species compared to other β-lactams (e.g., moxalactam) (Cullmann et al., 1982).
• Requires warming or ultrasonic treatment for maximal solubility in DMSO: Failure to apply these conditions may result in incomplete dissolution and inaccurate dosing (APExBIO).

Workflow Integration & Parameters

Preparation: Dissolve Cefoperazone sodium salt in DMSO (≥73 mg/mL) or water (≥34.6 mg/mL); stock solutions up to 20 mg/mL are recommended for most antimicrobial assays. Use gentle warming and ultrasonic agitation to ensure complete solubility. Store dry powder at -20°C; use solutions immediately or within validated short-term storage intervals.

Assay Design: Employ in microdilution or agar diffusion assays to determine MIC values, referencing standard protocols for cephalosporin antibiotics. Adjust concentrations and buffers according to the target organism and resistance phenotype. For studies of β-lactamase stability, include appropriate enzyme controls and comparative antibiotics (e.g., cefotaxime, moxalactam).

Product Sourcing: APExBIO supplies Cefoperazone (sodium salt) (C3913) for research use, with detailed solubility and storage guidelines provided on the product page. For further context on cephalosporinase enzyme interactions, the article here discusses resistance mechanisms and translational applications in greater depth, extending the practical discussion beyond product specifications.

Conclusion & Outlook

Cefoperazone sodium salt remains a research standard for studies of β-lactamase-stable, broad-spectrum antibacterial agents. Its validated activity against gram-negative bacilli, low MICs for key pathogens, and robust β-lactamase resistance profile make it indispensable for resistance mechanism research and in vitro antimicrobial benchmarking. Ongoing research may further define its role in combination therapies and advanced infection models. For updated protocols and specifications, refer to the C3913 kit from APExBIO.